$RS

Ajemyan Arthur sold $902K of RS

Ajemyan Arthur (SVP, CFO) sold 2,200 shares of RELIANCE, INC. (RS) at $410.11 ($0.90M total) on 2026-07-31.

Original reporting
SEC EDGAR · Ajemyan Arthur
Published Aug 4, 2026, 12:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 1:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RS
Neutral
low confidence
Mentioned
$RS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RSNeutralLow
01

Why it matters

The newest disclosed fact is the open-market sale size, price, and post-transaction holdings. It may slightly affect sentiment but does not change operating outlook.

02

Market read

Traders may note insider selling as a minor sentiment input, but there is no fundamental update in the text.

03

What to watch

The filing does not disclose intent, remaining compensation structure, or whether other insiders are buying; without follow-on buys or company news, signal quality is low.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-04, covering a sale dated 2026-07-31

Background

The article is an SEC Form 4 insider transaction disclosure for Reliance, Inc. (RS) by CFO Ajemyan Arthur.

Company-level read

Ticker impact

$RSNeutralLow confidence
Context

RS discloses CFO Ajemyan Arthur sold 2,200 shares for about $902K via an open-market sale on 2026-07-31.

Expected impact

Likely minimal near-term impact; any reaction would be sentiment-driven and typically fades.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the filing provides transaction details but no accompanying company-specific news.

Market effects

None; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan does not necessarily imply bearish information; sales can be driven by taxes, diversification, or pre-scheduled personal liquidity needs.

Key entities

  • RELIANCE, INC.

    Company filing the Form 4 insider transaction disclosure.

  • Ajemyan Arthur

    SVP, CFO who reported the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RSMedAI 8/10

Jim Cramer Prefers Nucor (NUE) Over Reliance (RS)

Jim Cramer prefers Nucor (NUE) over Reliance (RS) but acknowledges RS's strength. Both companies reported strong Q2 results: RS revenue up 26.5% YoY, EPS up 41.5%; NUE EPS up to $5.04. Both expect higher steel prices but lower raw materials margins. Hedge fund holdings increased for both.

$RSMed

Reliance, Inc. Reports Second Quarter 2026 Financial Results

RELIANCE, INC. (RS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Reliance, Inc. Reports Second Quarter 2026 Financial Results - Net sales of $4.63 billion, up 15% sequentially with record tons sold up 7.0% - EPS of $6.29; non-GAAP EPS of $6.27, up 42% year-over-year, exceeding expect

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $2.2M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 103,684 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $20.92 ($20.80–$21.09, $2.17M total) across 3 trades over 2026-10-02 to 2026-10-06. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Zolezzi William (10% owner), Divisadero Street Partners, L.P. (10% owner) and Divisadero Street Capital, LLC (10% owner).